Blacktrace Holdings Ltd. to in-license PerkinElmer Technology
News Aug 04, 2014
Blacktrace Holdings Limited today announced that it has entered into an agreement with PerkinElmer to license certain microfluidic technology owned by its subsidiary, Caliper Life Sciences, Inc., for a wide range of applications. The Blacktrace group includes a number of well-known brands. Dolomite Microfluidics is a leading solution provider of systems and components such as microfluidic droplet systems, microfluidic chips, pumps and connectors, as well as custom solutions and bespoke product development services. Syrris is a leader in chemistry tools, with its award-winning 4th generation Asia Flow Chemistry System being the most successful flow reactor ever.
The license provides Blacktrace with maximum flexibility as it expands its product ranges to include more microfluidic chips and technology, and develops new innovative platforms that will deliver superior performance to its customers worldwide. PerkinElmer continues to leverage its microfluidics portfolio through licensing collaborations to extend its market reach.
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE
Cancer Cells Force Normal Cells to Act Like Viruses, Helping Tumors SpreadNews
Researchers reveal how cancer cells force normal cells to act like viruses – allowing tumors to grow, resist treatment, and spread.READ MORE
Comments | 0 ADD COMMENT
EMBL Conference: European Conference of Life Science Funders and Foundations
Apr 19 - Apr 20, 2018
EMBL Course: Target Engagement in Biology and Drug Discovery
Feb 19 - Feb 23, 2018